title: Treating hyperlipidemia, Part III: Drug therapy.
abstract: In elderly patients at increased risk for cardiovascular disease due to lipid abnormalities, numerous medications are available for altering such abnormalities. Most of these drugs have side effects which, in the elderly, may necessitate lower dosing than usual. For persons with severe elevations of triglycerides, nicotinic acid (Niacin) and gemfibrozil (Lopid) may be used. For those who need a reduction in the LDL cholesterol, choices include bile acid-binding resins, nicotinic acid, HMG CoA reductase inhibitors, probucol (Lorelco), and neomycin.
mesh_terms: D000368:Aged; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D015248:Gemfibrozil; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D009281:Naphthalenes / Q000008:administration & dosage / Q000627:therapeutic use; D009355:Neomycin / Q000008:administration & dosage / Q000627:therapeutic use; D009525:Niacin / Q000008:administration & dosage / Q000627:therapeutic use; D010421:Pentanoic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D017035:Pravastatin
chemical_list: D004791:Enzyme Inhibitors; D006538:Heptanoic Acids; D000960:Hypolipidemic Agents; D009281:Naphthalenes; D010421:Pentanoic Acids; D009525:Niacin; D009355:Neomycin; D017035:Pravastatin; D015248:Gemfibrozil